Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations

Clinical trial NCT03786796 · RECRUITING

Trial details

NCT number: NCT03786796
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma Metastatic Renal Cell Carcinoma Kidney Cancer Renal Carcinoma Kidney Cancer Metastatic

Start date: 2019-06-03
Primary completion: 2027-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.